NRCC
NOTICE OF REGISTRATION CONFIRMATION EMAILED
10/24/2023
Back to search
Official data from USPTO
SANAVIA ONCOLOGY
Did you know this trademark is already registered in United States?
Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.
Active USPTO registrationType: CombinedOffice: United States
Risk and opportunity diagnosis
Executive reading for naming, filing, and monitoring decisions.
USPTO status
Active USPTO registration
Case type
Application and registration
Recorded events
40
Latest update
10/24/2023
Trademark type
Combined
Nice classes
42
Filing date
01/05/2022
Registration date
10/24/2023
Expiration date
-
Complete case details
Structured fields from the responsible authority and the official record.
Status date
10/24/2023
Last transaction
10/24/2023
Responsible office
United States Patent and Trademark Office
Status code
700
Official register
Principal Register
Filing basis
Intent to use
First use anywhere
03/01/2022
First use in commerce
03/01/2022
Drawing code
3
Owner type
03
Owner location
New York, NY, US
Examiner
MICKLEBURGH, LINDA BOHANNON
Law office
L60
Current location
PUBLICATION AND ISSUE SECTION
Mark description
The mark consists of the terms "SANAVIA" and "ONCOLOGY", with the former term designed in a bold lowercase font that has a border emanating from the dotted "i" that extends and surrounds the term, and the term "ONCOLOGY" located below, in a smaller though sharper and lighter font that uses capital letters.
Holders and representatives
Holders
Sanavia Oncology Inc.
Representatives
David Mitnick
Technical classification
Nice Classes
Class 42
Vienna Codes
No Vienna codes available.
Goods and services
Class 42
Research and development of diagnostics and therapeutics for the detection and treatment of cancer
Publications
History of USPTO decisions and trademark events.
40 publications found
R.PR
REGISTERED-PRINCIPAL REGISTER
10/24/2023
SUNA
NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
09/19/2023
CNPR
ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
09/18/2023
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
09/16/2023
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
09/16/2023
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
09/15/2023
GNRN
NOTIFICATION OF NON-FINAL ACTION E-MAILED
09/15/2023
GNRT
NON-FINAL ACTION E-MAILED
09/15/2023
CNRT
SU - NON-FINAL ACTION - WRITTEN
09/15/2023
EXRA
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
09/12/2023
SUPC
STATEMENT OF USE PROCESSING COMPLETE
09/11/2023
EX1G
SOU EXTENSION 1 GRANTED
09/11/2023
AITU
CASE ASSIGNED TO INTENT TO USE PARALEGAL
09/08/2023
IUAF
USE AMENDMENT FILED
08/30/2023
NREV
NOTICE OF REVIVAL - E-MAILED
08/30/2023
EISU
TEAS STATEMENT OF USE RECEIVED
08/30/2023
TPEX
SOU EXTENSION RECEIVED WITH TEAS PETITION
08/30/2023
PETG
PETITION TO REVIVE-GRANTED
08/30/2023
PROA
TEAS PETITION TO REVIVE RECEIVED
08/30/2023
MAB6
ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED
08/28/2023
ABN6
ABANDONMENT - NO USE STATEMENT FILED
08/28/2023
EXT1
SOU EXTENSION 1 FILED
07/24/2023
NOAM
NOA E-MAILED - SOU REQUIRED FROM APPLICANT
01/24/2023
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
11/29/2022
PUBO
PUBLISHED FOR OPPOSITION
11/29/2022
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
11/09/2022
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
10/24/2022
XAEC
EXAMINER'S AMENDMENT ENTERED
10/21/2022
ALIE
ASSIGNED TO LIE
10/21/2022
GNEN
NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
10/21/2022
GNEA
EXAMINERS AMENDMENT E-MAILED
10/21/2022
CNEA
EXAMINERS AMENDMENT -WRITTEN
10/21/2022
GNRN
NOTIFICATION OF NON-FINAL ACTION E-MAILED
10/14/2022
GNRT
NON-FINAL ACTION E-MAILED
10/14/2022
CNRT
NON-FINAL ACTION WRITTEN
10/14/2022
DOCK
ASSIGNED TO EXAMINER
10/11/2022
MDSM
NOTICE OF DESIGN SEARCH CODE E-MAILED
01/11/2022
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
01/10/2022
NWAP
NEW APPLICATION ENTERED
01/08/2022
Continuous trademark protection
Get notified about every new filing that threatens SANAVIA ONCOLOGY or your mark.
Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.